Orchestra BioMed
OBIO
#8900
Rank
A$0.17 B
Marketcap
$4.57
Share price
-11.25%
Change (1 day)
-39.49%
Change (1 year)

Orchestra BioMed (OBIO) - Cash on Hand

Cash on Hand as of September 2024 : A$0.11 Billion

According to Orchestra BioMed 's latest financial reports the company has A$0.11 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Orchestra BioMed - Cash on Hand chart (from 2021 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31A$0.12 B4.43%
2022-12-31A$0.12 B719.21%
2021-12-31A$15.02 M-67.71%
2020-12-31A$46.54 M